192 related articles for article (PubMed ID: 33641250)
1. Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators.
Hughes SM; Pandey U; Johnston C; Marrazzo J; Hladik F; Micks E
Am J Reprod Immunol; 2021 Aug; 86(2):e13412. PubMed ID: 33641250
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
4. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Duijkers I; Klipping C; Heger-Mahn D; Fayad GN; Frenkl TL; Cruz SM; Korver T
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):245-254. PubMed ID: 30203681
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.
Roumen FJ; Apter D; Mulders TM; Dieben TO
Hum Reprod; 2001 Mar; 16(3):469-75. PubMed ID: 11228213
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol.
Apter D; Cacciatore B; Stenman UH; Alapiessa U; Assendorp R
Contraception; 1990 Sep; 42(3):285-95. PubMed ID: 2149697
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
[TBL] [Abstract][Full Text] [Related]
9. Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.
Hughes SM; Levy CN; Katz R; Lokken EM; Anahtar MN; Hall MB; Bradley F; Castle PE; Cortez V; Doncel GF; Fichorova R; Fidel PL; Fowke KR; Francis SC; Ghosh M; Hwang LY; Jais M; Jespers V; Joag V; Kaul R; Kyongo J; Lahey T; Li H; Makinde J; McKinnon LR; Moscicki AB; Novak RM; Patel MV; Sriprasert I; Thurman AR; Yegorov S; Mugo NR; Roxby AC; Micks E; Hladik F;
BMC Med; 2022 Oct; 20(1):353. PubMed ID: 36195867
[TBL] [Abstract][Full Text] [Related]
10. Vaginal ring contraception.
Kerns J; Darney P
Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
[TBL] [Abstract][Full Text] [Related]
11. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
Calhoun A; Ford S; Pruitt A
Headache; 2012 Sep; 52(8):1246-53. PubMed ID: 22789073
[TBL] [Abstract][Full Text] [Related]
12. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
Verhoeven CH; Dieben TO
Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
[TBL] [Abstract][Full Text] [Related]
13. The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
Wagner MS; Arias RD; Nucatola DL
Expert Opin Pharmacother; 2007 Aug; 8(11):1769-77. PubMed ID: 17685892
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
Dragoman M; Petrie K; Torgal A; Thomas T; Cremers S; Westhoff CL
Contraception; 2013 Apr; 87(4):432-6. PubMed ID: 23312933
[TBL] [Abstract][Full Text] [Related]
15. Ovarian activity during regular oral contraceptive use.
Crosignani PG; Testa G; Vegetti W; Parazzini F
Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
17. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
18. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
[TBL] [Abstract][Full Text] [Related]
19. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
Haaland RE; Holder A; Evans-Strickfaden T; Nyagol B; Makanga M; Oyaro B; Humwa F; Williams T; McLellan-Lemal E; Desai M; Huey MJ
Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.
Stifani BM; Plagianos M; Vieira CS; Merkatz RB
Contraception; 2018 May; 97(5):415-421. PubMed ID: 29269252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
